Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

A Subset of Type I Conventional Dendritic Cells Controls Cutaneous Bacterial Infections through VEGFα-Mediated Recruitment of Neutrophils.

Janela B, Patel AA, Lau MC, Goh CC, Msallam R, Kong WT, Fehlings M, Hubert S, Lum J, Simoni Y, Malleret B, Zolezzi F, Chen J, Poidinger M, Satpathy AT, Briseno C, Wohn C, Malissen B, Murphy KM, Maini AA, Vanhoutte L, Guilliams M, Vial E, Hennequin L, Newell E, Ng LG, Musette P, Yona S, Hacini-Rachinel F, Ginhoux F.

Immunity. 2019 Apr 16;50(4):1069-1083.e8. doi: 10.1016/j.immuni.2019.03.001. Epub 2019 Mar 27.

PMID:
30926233
2.

Identification of CD39 as a Marker for the Circulating Malignant T-Cell Clone of Sézary Syndrome Patients.

Bensussan A, Janela B, Thonnart N, Bagot M, Musette P, Ginhoux F, Marie-Cardine A.

J Invest Dermatol. 2019 Mar;139(3):725-728. doi: 10.1016/j.jid.2018.09.026. Epub 2018 Oct 25. No abstract available.

PMID:
30798854
3.

Ezh2 Controls Skin Tolerance through Distinct Mechanisms in Different Subsets of Skin Dendritic Cells.

Loh JT, Lim TJF, Ikumi K, Matoba T, Janela B, Gunawan M, Toyama T, Bunjamin M, Ng LG, Poidinger M, Morita A, Ginhoux F, Yamazaki S, Lam KP, Su IH.

iScience. 2018 Dec 21;10:23-39. doi: 10.1016/j.isci.2018.11.019. Epub 2018 Nov 14.

4.

Calcineurin-mediated IL-2 production by CD11chighMHCII+ myeloid cells is crucial for intestinal immune homeostasis.

Mencarelli A, Khameneh HJ, Fric J, Vacca M, El Daker S, Janela B, Tang JP, Nabti S, Balachander A, Lim TS, Ginhoux F, Ricciardi-Castagnoli P, Mortellaro A.

Nat Commun. 2018 Mar 16;9(1):1102. doi: 10.1038/s41467-018-03495-3.

5.

New Insights into Drug Reaction with Eosinophilia and Systemic Symptoms Pathophysiology.

Musette P, Janela B.

Front Med (Lausanne). 2017 Dec 4;4:179. doi: 10.3389/fmed.2017.00179. eCollection 2017. Review.

6.

Enterococcus faecalis Modulates Immune Activation and Slows Healing During Wound Infection.

Chong KKL, Tay WH, Janela B, Yong AMH, Liew TH, Madden L, Keogh D, Barkham TMS, Ginhoux F, Becker DL, Kline KA.

J Infect Dis. 2017 Dec 19;216(12):1644-1654. doi: 10.1093/infdis/jix541.

7.

Human fetal dendritic cells promote prenatal T-cell immune suppression through arginase-2.

McGovern N, Shin A, Low G, Low D, Duan K, Yao LJ, Msallam R, Low I, Shadan NB, Sumatoh HR, Soon E, Lum J, Mok E, Hubert S, See P, Kunxiang EH, Lee YH, Janela B, Choolani M, Mattar CNZ, Fan Y, Lim TKH, Chan DKH, Tan KK, Tam JKC, Schuster C, Elbe-Bürger A, Wang XN, Bigley V, Collin M, Haniffa M, Schlitzer A, Poidinger M, Albani S, Larbi A, Newell EW, Chan JKY, Ginhoux F.

Nature. 2017 Jun 29;546(7660):662-666. doi: 10.1038/nature22795. Epub 2017 Jun 14.

8.

Whole metagenome profiling reveals skin microbiome-dependent susceptibility to atopic dermatitis flare.

Chng KR, Tay AS, Li C, Ng AH, Wang J, Suri BK, Matta SA, McGovern N, Janela B, Wong XF, Sio YY, Au BV, Wilm A, De Sessions PF, Lim TC, Tang MB, Ginhoux F, Connolly JE, Lane EB, Chew FT, Common JE, Nagarajan N.

Nat Microbiol. 2016 Jul 11;1(9):16106. doi: 10.1038/nmicrobiol.2016.106.

PMID:
27562258
9.

Cdk2 catalytic activity is essential for meiotic cell division in vivo.

Chauhan S, Diril MK, Lee JH, Bisteau X, Manoharan V, Adhikari D, Ratnacaram CK, Janela B, Noffke J, Ginhoux F, Coppola V, Liu K, Tessarollo L, Kaldis P.

Biochem J. 2016 Sep 15;473(18):2783-98. doi: 10.1042/BCJ20160607. Epub 2016 Jul 1.

PMID:
27371320
10.

Protocols for the Identification and Isolation of Antigen-Presenting Cells in Human and Mouse Tissues.

McGovern N, Schlitzer A, Janela B, Ginhoux F.

Methods Mol Biol. 2016;1423:169-80. doi: 10.1007/978-1-4939-3606-9_12.

PMID:
27142016
11.

CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

Alexander KA, Flynn R, Lineburg KE, Kuns RD, Teal BE, Olver SD, Lor M, Raffelt NC, Koyama M, Leveque L, Le Texier L, Melino M, Markey KA, Varelias A, Engwerda C, Serody JS, Janela B, Ginhoux F, Clouston AD, Blazar BR, Hill GR, MacDonald KP.

J Clin Invest. 2014 Oct;124(10):4266-80. doi: 10.1172/JCI75935. Epub 2014 Aug 26.

12.

Recurrence of drug-induced reactions in DRESS patients.

Picard D, Vellar M, Janela B, Roussel A, Joly P, Musette P.

J Eur Acad Dermatol Venereol. 2015 Apr;29(4):801-4. doi: 10.1111/jdv.12419. Epub 2014 Mar 13.

PMID:
24628777
13.

Prolonged evolution of drug reaction with eosinophilia and systemic symptoms: clinical, virologic, and biological features.

Tetart F, Picard D, Janela B, Joly P, Musette P.

JAMA Dermatol. 2014 Feb;150(2):206-7. doi: 10.1001/jamadermatol.2013.6698. No abstract available.

PMID:
24369386
14.

Poor benefit/risk balance of intravenous immunoglobulins in DRESS.

Joly P, Janela B, Tetart F, Rogez S, Picard D, D'Incan M, Descamps V, Collet E, Roujeau JC, Musette P.

Arch Dermatol. 2012 Apr;148(4):543-4. doi: 10.1001/archderm.148.4.dlt120002-c. No abstract available.

PMID:
22508885
15.

Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response.

Picard D, Janela B, Descamps V, D'Incan M, Courville P, Jacquot S, Rogez S, Mardivirin L, Moins-Teisserenc H, Toubert A, Benichou J, Joly P, Musette P.

Sci Transl Med. 2010 Aug 25;2(46):46ra62. doi: 10.1126/scitranslmed.3001116.

Supplemental Content

Loading ...
Support Center